Navigation Links
AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial

than 50% of men 60 years and over, with approximately 56 million cases in the U.S., Europe and Japan. In 2004, BPH treatment represented a market size of over US$4 billion. Contrary to most of the present treatments for BPH, cetrorelix is not associated with side-effects such as erectile dysfunction, loss of libido and chemical castration. According to Decision Resource, cetrorelix is currently the most advanced LHRH antagonist in development for the treatment of BPH.

About Cetrorelix

Cetrorelix is part of AEterna Zentaris' LHRH antagonist therapeutic approach. This peptide-based active substance was developed by the Company in cooperation with Nobel-Prize winner Professor Andrew Schally of the U.S. Veterans Administration in Miami and the University of Miami.

Cetrorelix is marketed under the brand name Cetrotide(R), the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe, the USA and Japan. It was launched on the market through Merck Serono in the USA, Europe and in several other countries, as well as in Japan through Shionogi.

AEterna Zentaris is currently conducting a large Phase 3 program with cetrorelix in BPH while the Company's partner, Solvay is sponsoring a pivotal clinical program for endometriosis with this same compound.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a late-stage global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking s
'"/>




Page: 1 2 3 4

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
(Date:12/16/2009)... Dec. 16 DATATRAK International, Inc. ... focused on global eClinical solutions for the ... of its version 9.0 eClinical Software. ... for product and service delivery and introduces ... Knowledge(TM) offering: the DATATRAK Learning Center(TM) and ...
(Date:12/16/2009)... 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) ... secured $1 million in 12% per annum short term ... is an initial drawdown of $500,000, with accrued interest ... of $500,000 with accrued interest and principal repayable in ... Company becoming cashflow positive for any calendar month prior ...
(Date:12/16/2009)... -- Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ) ... version of a common single-letter variant in the ... impact on susceptibility to type 2,diabetes (T2D). The ... large, but unusual:,if an individual inherits it from ... more than 30% compared to those who inherit ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 0A 59675 1Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 0A 59675 2Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 1Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 1Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 3Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 4Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 5Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 6Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 7Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 8Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 9
... in severely-injured, acute ... HOPKINTON, Mass., May 12 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... I/IIa clinical trial of Cethrin, a proprietary recombinant,protein that ... and,sensory function after spinal cord injury, or SCI. The ...
... 12 GlaxoSmithKline (GSK),in collaboration with the Breast ... network, and one of its member groups, the,Spanish ... start,of a global Phase III study that will ... early breast cancer. Neo-ALTTO (Neoadjuvant Lapatinib and/or,Trastuzumab Treatment ...
Other Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7
(Date:12/17/2009)... HONG KONG, Dec. 17 /PRNewswire-Asia/ -- China,s leading ... or "the,Group"; Stock Code: 801) is pleased to ... During the period under review, the Group,s two,associate ... Stock Exchange and NASDAQ;,its key businesses have been ... new hospital management operations. , ...
(Date:12/17/2009)... 17, 2009 Canadian teenagers are among the largest ... illicit drug on young brains are worse than originally ... a psychiatric researcher from the Research Institute of the ... Neurobiology of Disease , suggests that daily consumption ... and have an irreversible long-term effect on the brain. ...
(Date:12/17/2009)... (Rutherfordton, N.C.), a management client since 1983, and Sturgis ... recently recognized as top-ranked Community Value Providers by Cleverley ... ... Brentwood, Tenn. (PRWEB) December 17, 2009 -- Quorum ... a management client since 1983, and Sturgis Hospital (Sturgis, ...
(Date:12/17/2009)... quality standards. Open to primary care doctors who agree to ... reimbursement for commonly billed services, , ... ... Blue Cross and Blue Shield of North Carolina (BCBSNC) ... North Carolina by introducing a new reimbursement model for participating ...
(Date:12/17/2009)... 17, 2009 The Amerigroup ... at its first ,Breakfast of Champions, awards celebration ... was local television personality, Barbara Ciara, managing editor ... keynote speaker was world-renowned ,champion, and four-time heavyweight ... a packed house of Amerigroup ,Real Caring, volunteers ...
Breaking Medicine News(10 mins):Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 3Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 2Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 3
... And more than half aren,t worrying about their health, survey ... half of smokers aren,t fretting over their personal health, and ... discussed their tobacco use with that person, a new online ... smokers, which was commissioned by an anti-smoking organization, also found ...
... The California Association of Health Plans (CAHP) is ... Awareness Day by increasing awareness about the wide ... for autism."California health plans understand the inherent challenges ... mental health conditions," said CAHP Interim President Charles ...
... Electronics Maximizes Investment in Flat-Screen HD Televisions SIOUX ... division of LodgeNet Interactive Corporation (Nasdaq: ... high-definition (HD) Interactive Patient Television System at the ... Conference and Convention next week in Chicago. LodgeNet ...
... living with autism, and sharing the results of Easter Seals Living With ... families living with autism desperately need. , ... New York, April 2, ... services for individuals living with autism, and sharing the results of Easter ...
... Health plan members who individually purchase their plans ... satisfied with their health plan experience, compared with ... according to the J.D. Power and Associates 2009 ... today.(Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a )Now in its third ...
... with Allen Cardoza , Los Angeles, California, April ... 2 Our special guest this week is Dr. ... practice. Shelly has been a coach and presenter to ... as a Doctor of Psychology and a Licensed Marriage ...
Other Medicine News:Health News:Many Smokers Don't Tell Docs About Their Habit 2Health News:Many Smokers Don't Tell Docs About Their Habit 3Health News:California Association of Health Plans Recognizes World Autism Awareness Day by Highlighting Medical Services Plans Provide 2Health News:LodgeNet Healthcare Provides Industry's First Integrated High-Definition Interactive System for Hospitals 2Health News:LodgeNet Healthcare Provides Industry's First Integrated High-Definition Interactive System for Hospitals 3Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 2Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 3Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 4Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 5Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans is Notably Lower among Individual Purchasers and Small Employer Members 2Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans is Notably Lower among Individual Purchasers and Small Employer Members 3Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans is Notably Lower among Individual Purchasers and Small Employer Members 4Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans is Notably Lower among Individual Purchasers and Small Employer Members 5Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans is Notably Lower among Individual Purchasers and Small Employer Members 6
... Prostate Stepper Template Set is the HDR ... seed implantation technique. The template set consists ... can be sutured to the patient and ... variable ultrasound Grid Face Plates. The Stepper ...
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
Table mount stabilizer system...
The compact PT stepper is lightweight, user-friendly, and versatile. The perfect solution for a busy brachytherapy facility....
Medicine Products: